Fundraising Fox
Find your way into Dropprint Genomics
Sign up to see every warm intro you have to Dropprint Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dropprint Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
Founders & leadership· Y Combinator alumni (W20)
RG
Rachel GateCo-founder · Chief Executive Officer2019–2020Rachel Gate holds a PhD in bioinformatics from UCSF and cofounded Dropprint Genomics, which was acquired by Immunai. She currently develops new business initiatives in biotech.
MS
Meena SubramaniamCTO & Co-Founder2019–2021Meena Subramaniam is a computational biologist with experience in single-cell RNA sequencing and genomic data analysis for target discovery. She has previously founded and exited a startup, and has worked in seed-stage ventures collaborating on machine learning models and data processing infrastructure.
Investors · 1
Y Combinatorlisted by Y CombinatorSan Francisco · $500K
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 4
One CodexOne Codex provides microbiome sequencing data analysis and reporting software for academic labs, biotechnology companies, and clinical laboratories. The platform uses advanced algorithms and a curated database to analyze metagenomic samples with a web-based interface accessible to both bench scientists and computational biologists.
Luminist LabsLuminist Labs provided a non-invasive test to identify and assess the progression of liver fibrosis and NASH in patients. The company was acquired by DiscernDx in 2020.
BillionToOneBillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
Helix NanotechnologiesHelix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
Companies working in the same space as Dropprint Genomics.
Legal entities · 1
corporate structureDropprint Genomics Inc.
Frequently asked questions
- What does Dropprint Genomics do?
- Dropprint Genomics develops software for analyzing individual cell activity in genomic data, serving researchers in immunology and drug discovery. The company reduces the cost and computational complexity of single-cell sequencing and maintains a database of over 1 million immune cells to support target identification using machine learning models.
- Who founded Dropprint Genomics?
- Dropprint Genomics was founded by Rachel Gate, Meena Subramaniam, Jimmie Ye.
- Who are Dropprint Genomics's investors?
- Dropprint Genomics's investors include Y Combinator.
- Who acquired Dropprint Genomics?
- Dropprint Genomics was acquired by Immunai.
- Where is Dropprint Genomics headquartered?
- Dropprint Genomics is headquartered in San Francisco, US.